Young-Woo Sohn - Related publications

Psychology Yonsei University, Seoul, South Korea 
Memory, Skill Acquisition, HCI
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Chen F, Li Y, Ye G, Zhou L, Bian X, Liu J. Development and Validation of a Prognostic Model for Cognitive Impairment in Parkinson's Disease With REM Sleep Behavior Disorder. Frontiers in Aging Neuroscience. 13: 703158. PMID 34322014 DOI: 10.3389/fnagi.2021.703158   
2021 Fernandes M, Pierantozzi M, Stefani A, Cattaneo C, Bonizzoni EA, Cerroni R, Mercuri NB, Liguori C. Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations. Frontiers in Neurology. 12: 678373. PMID 34267721 DOI: 10.3389/fneur.2021.678373   
2021 Romic I, Augustin G, Bogdanic B, Bruketa T, Moric T. Laser treatment of pilonidal disease: a systematic review. Lasers in Medical Science. PMID 34291332 DOI: 10.1007/s10103-021-03379-x   
2021 Niemeijer AN, Oprea Lager DE, Huisman MC, Hoekstra OS, Boellaard R, van de Veen B, Bahce I, Vugts DJ, van Dongen GA, Thunnissen E, Smit E, de Langen AJ. First-in-human study of Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34272316 DOI: 10.2967/jnumed.121.261926   
2021 Nuuttila S, Eklund M, Joutsa J, Jaakkola E, Mäkinen E, Honkanen EA, Lindholm K, Noponen T, Ihalainen T, Murtomäki K, Nojonen T, Levo R, Mertsalmi T, Scheperjans F, Kaasinen V. Diagnostic accuracy of glabellar tap sign for Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 34328563 DOI: 10.1007/s00702-021-02391-3   
2021 Sasaki S. High Prevalence of Early Parkinson's Disease in Patients With Subtle Parkinsonian Signs. Frontiers in Neurology. 12: 656679. PMID 34305780 DOI: 10.3389/fneur.2021.656679   
2021 Zhang F, Zhu X, Zhang Q, Zhou P, Hao L. Programmed cell death-ligand 1 expression predicts poor treatment response and prognostic value in esophageal squamous cell carcinoma patients without esophagectomy. Aging. 13. PMID 34297698 DOI: 10.18632/aging.203326   
2021 Zhang F, Zhu X, Zhang Q, Zhou P, Hao L. Programmed cell death-ligand 1 expression predicts poor treatment response and prognostic value in esophageal squamous cell carcinoma patients without esophagectomy. Aging. 13. PMID 34297698 DOI: 10.18632/aging.203326   
2021 Shieh KR, Huang A, Xu Y. Response to Immune Checkpoint Inhibitor Treatment in Advanced Cervical Cancer and Biomarker Study. Frontiers in Medicine. 8: 669587. PMID 34458284 DOI: 10.3389/fmed.2021.669587   
2021 Poonja S, Miyasaki J, Fu X, Camicioli R, Sang T, Yuan Y, Ba F. The Trajectory of Motor Deterioration to Death in Parkinson's Disease. Frontiers in Neurology. 12: 670567. PMID 34484095 DOI: 10.3389/fneur.2021.670567   
2021 Brendel M, Su C, Hou Y, Henchcliffe C, Wang F. Comprehensive subtyping of Parkinson's disease patients with similarity fusion: a case study with BioFIND data. Npj Parkinson's Disease. 7: 83. PMID 34535682 DOI: 10.1038/s41531-021-00228-0   
2021 Dart SJ, Cook AM, Millward MJ, McDonnell AM, Chin WL, Hakeem MU, Meniawy TM, Bowyer SE. Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors. Scientific Reports. 11: 15312. PMID 34321489 DOI: 10.1038/s41598-021-93479-z   
2021 Salari M, Etemadifar M, Zali A, Aminzade Z, Navalpotro-Gomez I, Fateh ST. Neurologia (Barcelona, Spain). PMID 34366530 DOI: 10.1016/j.nrl.2021.07.002   
2021 Que Y, Wang J, Zhu J, Li N, Huang J, Lu S, Sun F, Zhang L, Zhen Z, Zhang L, Cai R, Guo H, Sun X, Zhang Y. Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer. Frontiers in Immunology. 12: 647733. PMID 34295326 DOI: 10.3389/fimmu.2021.647733   
2021 Santos García D, Blázquez-Estrada M, Calopa M, Escamilla-Sevilla F, Freire E, García Ruiz PJ, Grandas F, Kulisevsky J, López-Manzanares L, Martínez Castrillo JC, Mir P, Pagonabarraga J, Pérez-Errazquin F, Salom JM, Tijero B, et al. Present and Future of Parkinson's Disease in Spain: PARKINSON-2030 Delphi Project. Brain Sciences. 11. PMID 34439646 DOI: 10.3390/brainsci11081027   
2021 Chen W, Wang M, Wang N, Du C, Ma X, Li Q. The Impacts of Subthalamic Nucleus-Deep Brain Stimulation (STN-DBS) on the Neuropsychiatric Function of Patients with Parkinson's Disease Using Image Features of Magnetic Resonance Imaging under the Artificial Intelligence Algorithms. Contrast Media & Molecular Imaging. 2021: 9915206. PMID 34345227 DOI: 10.1155/2021/9915206   
2021 Holanda VM, Eisinger RS, Almeida L, Tsuboi T, Wang H, Okun MS, Deeb W, Patterson A, Wagle Shukla A, Lobo Lopes J, Foote KD. Evolution of Globus Pallidus Targeting for Parkinson's and Dystonia Deep Brain Stimulation: A 15-Year Experience. Frontiers in Neurology. 12: 679918. PMID 34456844 DOI: 10.3389/fneur.2021.679918   
2021 Qiao ZY, Zhang ZJ, Lv ZC, Tong H, Xi ZF, Wu HX, Chen XS, Xia L, Feng H, Zhang JJ, Xia Q. Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review. Frontiers in Immunology. 12: 653437. PMID 34349755 DOI: 10.3389/fimmu.2021.653437   
2021 Yokote A, Hayashi Y, Yanamoto S, Fujioka S, Higa K, Tsuboi Y. Leg Muscle Strength Correlates with Gait Performance in Advanced Parkinson Disease. Internal Medicine (Tokyo, Japan). PMID 34393165 DOI: 10.2169/internalmedicine.7646-21   
2021 Qiao Y, Liu C, Zhang X, Zhou Q, Li Y, Xu Y, Gao Z, Xu Y, Kong L, Yang A, Mei M, Ren Y, Wang X, Zhou X. PD-L2 based immune signature confers poor prognosis in HNSCC. Oncoimmunology. 10: 1947569. PMID 34377590 DOI: 10.1080/2162402X.2021.1947569   
2021 Alfano V, Longarzo M, Mele G, Esposito M, Aiello M, Salvatore M, Grossi D, Cavaliere C. Identifying a Common Functional Framework for Apathy Large-Scale Brain Network. Journal of Personalized Medicine. 11. PMID 34357146 DOI: 10.3390/jpm11070679   
2021 Herrera AF, Burton C, Radford J, Miall F, Townsend W, Santoro A, Zinzani PL, Lewis D, Fowst C, Brar S, Huang B, Thall A, Collins GP. Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial. Blood Advances. 5: 3387-3396. PMID 34477818 DOI: 10.1182/bloodadvances.2021004511   
2021 Ivan IF, Irincu VL, Diaconu Ș, Falup-Pecurariu O, Ciopleiaș B, Falup-Pecurariu C. Gastro-intestinal dysfunctions in Parkinson's disease (Review). Experimental and Therapeutic Medicine. 22: 1083. PMID 34447476 DOI: 10.3892/etm.2021.10517   
2021 Roh H, Kang J, Koh SB, Kim JH. Hippocampal volume is related to olfactory impairment in Parkinson's disease. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 34355455 DOI: 10.1111/jon.12911   
2021 Chien KS, Kim K, Nogueras-Gonzalez GM, Borthakur G, Naqvi K, Daver NG, Montalban-Bravo G, Cortes JE, DiNardo CD, Jabbour E, Alvarado Y, Andreeff M, Bose P, Jain N, Kadia TM, et al. Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome. British Journal of Haematology. PMID 34340254 DOI: 10.1111/bjh.17689   
2021 Yoo SW, Kim JS, Oh YS, Ryu DW, Ha S, Yoo JY, Lee KS. Cardiac sympathetic burden reflects Parkinson disease burden, regardless of high or low orthostatic blood pressure changes. Npj Parkinson's Disease. 7: 71. PMID 34385459 DOI: 10.1038/s41531-021-00217-3   
2021 Klempner SJ, Bendell JC, Villaflor VM, Tenner LL, Stein SM, Rottman JB, Naik GS, Sirard CA, Kagey MH, Chaney MF, Strickler JH. Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers. Molecular Cancer Therapeutics. PMID 34482288 DOI: 10.1158/1535-7163.MCT-21-0273   
2021 Mei J, Sun XQ, Lin WP, Li SH, Lu LH, Zou JW, Wei W, Guo RP. Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy. Journal of Inflammation Research. 14: 3879-3890. PMID 34408469 DOI: 10.2147/JIR.S325600   
2021 Domènech M, Muñoz Marmol AM, Mate JL, Estival A, Moran T, Cucurull M, Saigi M, Hernandez A, Sanz C, Hernandez-Gallego A, Urbizu A, Martinez-Cardus A, Bernat A, Carcereny E. Correlation between PD-L1 expression and gene amplification in patients with advanced non-small cell lung cancer and no other actionable oncogenic driver. Oncotarget. 12: 1802-1810. PMID 34504652 DOI: 10.18632/oncotarget.28045   
2021 Luis-Martínez R, Di Marco R, Weis L, Cianci V, Pistonesi F, Baba A, Carecchio M, Biundo R, Tedesco C, Masiero S, Antonini A. Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown. Bmc Neurology. 21: 332. PMID 34461838 DOI: 10.1186/s12883-021-02364-9   
2021 Liu Q, Zhao C, Jiang P, Liu D. Circulating tumor cells counts are associated with CD8+ T cell levels in programmed death-ligand 1-negative non-small cell lung cancer patients after radiotherapy: A retrospective study. Medicine. 100: e26674. PMID 34398034 DOI: 10.1097/MD.0000000000026674   
2021 Abou Dalle I, Kantarjian H, Daver N, Masarova L, Pemmaraju N, Bose P, Garcia-Manero G, Verstovsek S. Phase II study of single-agent nivolumab in patients with myelofibrosis. Annals of Hematology. PMID 34350483 DOI: 10.1007/s00277-021-04618-5   
2021 Zhu X, Liu L, Xiao Y, Li F, Huang Y, Han D, Yang C, Pan S. Abnormal Topological Network in Parkinson's Disease With Impulse Control Disorders: A Resting-State Functional Magnetic Resonance Imaging Study. Frontiers in Neuroscience. 15: 651710. PMID 34497483 DOI: 10.3389/fnins.2021.651710   
2021 Zaremba A, Eggermont AMM, Robert C, Dummer R, Ugurel S, Livingstone E, Ascierto PA, Long GV, Schadendorf D, Zimmer L. The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients. European Journal of Cancer (Oxford, England : 1990). 155: 268-280. PMID 34392069 DOI: 10.1016/j.ejca.2021.07.002   
2021 Hamedani AG, Maguire MG, Marras C, Willis AW. Prevalence and Risk Factors for Double Vision in Parkinson Disease. Movement Disorders Clinical Practice. 8: 709-712. PMID 34307743 DOI: 10.1002/mdc3.13220   
2021 Xu L, Liu L, Yao D, Zeng X, Zhang Y, Lai J, Zhong J, Zha X, Zheng R, Lu Y, Li M, Jin Z, Hebbar Subramanyam S, Chen S, Huang X, et al. PD-1 and TIGIT Are Highly Co-Expressed on CD8 T Cells in AML Patient Bone Marrow. Frontiers in Oncology. 11: 686156. PMID 34490086 DOI: 10.3389/fonc.2021.686156   
2021 He W, Wang JC, Tsai PY. Theta Burst Magnetic Stimulation Improves Parkinson's-Related Cognitive Impairment: A Randomised Controlled Study. Neurorehabilitation and Neural Repair. 1545968321104131. PMID 34467796 DOI: 10.1177/1545968321104131   
2021 Chung SJ, Cho KH, Lee YH, Yoo HS, Baik K, Jung JH, Ye BS, Sohn YH, Cha J, Lee PH. Diffusion tensor imaging-based pontine damage as a degeneration marker in synucleinopathy. Journal of Neuroscience Research. PMID 34521154 DOI: 10.1002/jnr.24926   
2021 Navarro-Fernandez I, Gonzalez-Vela C, Gomez-Fernandez C, Duran-Vian C, Reguero L, Gonzalez-Lopez M. Vitiligo-like Depigmentation in a Patient Undergoing Treatment with Nivolumab for Advanced Renal-cell Carcinoma. Acta Dermatovenerologica Croatica : Adc. 291: 54-55. PMID 34477066   
2021 Schoenfeld AJ, Antonia SJ, Awad MM, Felip E, Gainor J, Gettinger SN, Hodi FS, Johnson ML, Leighl NB, Lovly CM, Mok T, Perol M, Reck M, Solomon B, Soria JC, et al. Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small cell lung cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 34487855 DOI: 10.1016/j.annonc.2021.08.2151   
2021 Chiang PJ, Xu T, Cha TL, Tsai YT, Liu SY, Wu ST, Meng E, Tsao CW, Kao CC, Chen CL, Sun GH, Yu DS, Chang SY, Yang MH. Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial Carcinoma. Biology. 10. PMID 34356529 DOI: 10.3390/biology10070674   
2021 Cui H, Li Y, Li S, Liu G. Prognostic Function of Programmed Cell Death-Ligand 1 in Esophageal Squamous Cell Carcinoma Patients Without Preoperative Therapy: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11: 693886. PMID 34490091 DOI: 10.3389/fonc.2021.693886   
2021 Okada Y, Ohtsuka H, Kamata N, Yamamoto S, Sawada M, Nakamura J, Okamoto M, Narita M, Nikaido Y, Urakami H, Kawasaki T, Morioka S, Shomoto K, Hattori N. Effectiveness of Long-Term Physiotherapy in Parkinson's Disease: A Systematic Review and Meta-Analysis. Journal of Parkinson's Disease. PMID 34366377 DOI: 10.3233/JPD-212782   
2021 Lee SH, Lin CC, Wei CH, Chang KP, Yuan CT, Tsai CH, Liu JH, Hou HA, Tang JL, Chou WC, Tien HF. PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients. The Journal of Pathology. Clinical Research. PMID 34480529 DOI: 10.1002/cjp2.240   
2021 Vellata C, Belli S, Balsamo F, Giordano A, Colombo R, Maggioni G. Effectiveness of Telerehabilitation on Motor Impairments, Non-motor Symptoms and Compliance in Patients With Parkinson's Disease: A Systematic Review. Frontiers in Neurology. 12: 627999. PMID 34512495 DOI: 10.3389/fneur.2021.627999   
2021 Smit J, Borm FJ, Niemeijer AN, Huisman MC, Hoekstra OS, Boellaard R, Oprea-Lager DE, Vugts DJ, van Dongen GA, de Wit-van der Veen BJ, Thunnissen E, Smit EF, de Langen AJ. PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34385342 DOI: 10.2967/jnumed.121.262473   
2021 Chen Z, Hong X, Wang T, Guo Y, Huang C, Li M, He X, Ju W, Chen M. Prognosis after liver transplantation in patients treated with anti- PD-1 immunotherapy for advanced hepatocellular carcinoma: case series. Annals of Palliative Medicine. PMID 34412496 DOI: 10.21037/apm-21-999   
2021 Ribas A, Medina T, Kirkwood JM, Zakharia Y, Gonzalez R, Davar D, Chmielowski B, Campbell KM, Bao R, Kelley H, Morris A, Mauro D, Wooldridge JE, Luke JJ, Weiner GJ, et al. Overcoming PD-1 Blockade Resistance With CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients With Metastatic Melanoma. Cancer Discovery. PMID 34326162 DOI: 10.1158/2159-8290.CD-21-0425   
2021 Friedman JH. Paroxysmal dyspnea in Parkinson's disease: Respiratory dyskinesias and autonomic hyperventilation are not the same. Parkinsonism & Related Disorders. PMID 34266744 DOI: 10.1016/j.parkreldis.2021.07.008   
2021 Rozas NS, Tribble GD, Jeter CB. Oral Factors That Impact the Oral Microbiota in Parkinson's Disease. Microorganisms. 9. PMID 34442695 DOI: 10.3390/microorganisms9081616